EMR News and Press, Emerson Electric Company From 02/09/23

Summary U.S. stock market indices started off the year notably strong as investors were quick to put a bruising 2022 in the rearview. The Moat Index’s outperformance in January, relative to the S&P 500 Index, was driven primarily by strong stock selection. The Morningstar...

Emerson Electric Co. (EMR) Q1 2023 Earnings Conference Call February 8, 2023 8:30 AM ET Company Participants Colleen Mettler – Vice President Investor Relations Lal Karsanbhai – President and Chief Executive Officer Frank Dellaquila – Chief Financi...

The following slide deck was published by Emerson Electric Co. in conjunction with their 2023 Q1 earnings call. For further details see: Emerson Electric Co. 2023 Q1 - Results - Earnings Call Presentation

Emerson Electric ( NYSE: EMR ) -2.1% pre-market Wednesday after missing estimates for FQ1 adjusted earnings and revenues , although the company raised its sales and earnings forecasts for FY 2023. Q4 profit increased by 2.5x to $2.33B, or $3.97/share, from $896M, $1.50/share, ...

Emerson Electric ( NYSE: EMR ) declares $0.52/share quarterly dividend , in line with previous. Forward yield 2.28% Payable March 10; for shareholders of record Feb. 17; ex-div Feb. 16. The company completed $2 billion of share repurchase in the first quarter. Se...

Emerson Electric press release ( NYSE: EMR ): Q1 Non-GAAP EPS of $0.78 misses by $0.09 . Revenue of $3.37B (+6.6% Y/Y) misses by $60M . The company expects Q2 adjusted EPS in the range of $0.95 to $1 vs. consensus of $0.95 and between $4 to $4.15 vs. consensus of $4.09...

Emerson Reports First Quarter 2023 Results; Updates 2023 Outlook PR Newswire Net sales were $3.4 billion , up 7 percent from the year prior; underlying sales 1 were up 6 percent Strong operational performance to start 2023 offset by foreign exchange and stock compe...

Emerson Electric ( NYSE: EMR ) is scheduled to announce FQ1 earnings results on Wednesday, February 8th, before market open. The consensus EPS Estimate is $0.87 (-32.6% Y/Y) and the consensus Revenue Estimate is $3.43B (-28.4% Y/Y). Over the last 2 years, EMR has beaten EPS ...

Summary Fortive beat sell-side expectations with strong results from the IOS and PT segments driving 14% organic growth and beats at the revenue and EBITA lines. A macro slowdown is a threat to Tektronix and Fluke, but Fortive has a good mix of less cyclical and acyclical businesses and...

Ovation Green will help producers navigate the emerging sustainable energy economy Emerson (NYSE: EMR) has combined its comprehensive power expertise and renewable energy capabilities into the Ovation™ Green portfolio to help power generation companies meet the needs of custo...